Conditions: Bronchial Asthma
Keywords: Asthma Symbicort
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 742
Healthy volunteers: no

Brief summary:
The purpose of the this study is to evaluate the efficacy and safety of 2 actuations Symbicort®pMDI® 40/2.25 μg twice daily compared with1 inhalation Symbicort Turbuhaler® 80/4.5 μg twice daily and 1 inhalation Pulmicort®Turbuhaler® 100 μg twice daily for 6 weeks.

Detailed description:

Arms:
arm 1: Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily arm 2: Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily arm 3: Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily

Interventions: intervention 1: Symbicort Turbuhaler intervention 2: Symbicort pMDI intervention 3: Pulmicort Turbuhaler
Intervention descriptions: intervention 1: Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily intervention 2: Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily intervention 3: Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily

Protocol document: